Early predictors of severity and mortality in COVID-19 hospitalized patients

Sehveta Mustafić1,2, Edin Jusufović2,3, Fatima Hukić1,2

  • 1Department of Laboratory Diagnostics, University Clinical Centre Tuzla, Tuzla, Bosnia and Herzegovina.

Insights

Elevated ferritin and decreased oxygen saturation are key indicators for predicting severe COVID-19 illness and mortality in hospitalized patients. These laboratory tests aid in early detection and prognosis.

Area of Science:

  • Infectious Diseases
  • Clinical Pathology
  • Biochemistry

Background:

  • Hospitalized COVID-19 patients face risks of severe illness and death.
  • Early identification of prognostic markers is crucial for patient management.
  • Laboratory parameters offer potential insights into disease progression.

Purpose of the Study:

  • To identify laboratory tests for early detection of severe COVID-19.
  • To predict disease progression and patient outcomes in hospitalized individuals.
  • To establish prognostic markers for COVID-19 severity and mortality.

Main Methods:

  • Prospective study of 66 hospitalized COVID-19 patients.
  • Stratification into moderate, severe, and critically ill groups.
  • Monitoring of clinical findings and laboratory parameters during hospitalization.

Main Results:

  • Critically ill patients exhibited higher white blood cell count, C-reactive protein, lactate dehydrogenase, and ferritin, with lower lymphocyte counts and oxygen saturation.
  • Fatal outcomes were associated with higher neutrophil, lactate dehydrogenase, and ferritin levels, alongside lower lymphocyte counts and oxygen saturation.
  • Lactate dehydrogenase, ferritin, and decreased oxygen saturation predicted progression to severe illness; ferritin and decreased oxygen saturation predicted fatal outcomes.

Conclusions:

  • Increased ferritin levels and decreased oxygen saturation are significant prognostic indicators for severe COVID-19 illness.
  • These parameters can help predict the development of critical illness and mortality in hospitalized COVID-19 patients.
  • Ferritin and oxygen saturation monitoring can aid in early risk stratification and clinical decision-making.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
548
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
310
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
538
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
596
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
435